CA2259496A1 - Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]pyrazine - Google Patents

Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]pyrazine Download PDF

Info

Publication number
CA2259496A1
CA2259496A1 CA002259496A CA2259496A CA2259496A1 CA 2259496 A1 CA2259496 A1 CA 2259496A1 CA 002259496 A CA002259496 A CA 002259496A CA 2259496 A CA2259496 A CA 2259496A CA 2259496 A1 CA2259496 A1 CA 2259496A1
Authority
CA
Canada
Prior art keywords
salt
solution
tartaric acid
enantiomer
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002259496A
Other languages
English (en)
French (fr)
Inventor
Philip Dietrich Hammen
Sally Gut Ruggeri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2259496A1 publication Critical patent/CA2259496A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002259496A 1996-07-01 1997-06-16 Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]pyrazine Abandoned CA2259496A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2051196P 1996-07-01 1996-07-01
US60/020,511 1996-07-01

Publications (1)

Publication Number Publication Date
CA2259496A1 true CA2259496A1 (en) 1998-01-08

Family

ID=21799016

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002259496A Abandoned CA2259496A1 (en) 1996-07-01 1997-06-16 Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]pyrazine

Country Status (16)

Country Link
EP (1) EP0912569A1 (tr)
JP (1) JPH11512751A (tr)
KR (1) KR20000022490A (tr)
CN (1) CN1221418A (tr)
AR (1) AR008251A1 (tr)
AU (1) AU2974497A (tr)
BR (1) BR9710018A (tr)
CA (1) CA2259496A1 (tr)
CZ (1) CZ434998A3 (tr)
ID (1) ID19779A (tr)
IL (1) IL127037A0 (tr)
PL (1) PL330962A1 (tr)
TR (1) TR199802743T2 (tr)
WO (1) WO1998000425A1 (tr)
YU (1) YU61098A (tr)
ZA (1) ZA975806B (tr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990008148A1 (en) * 1989-01-23 1990-07-26 Pfizer Inc. Bis-aza-bicyclic anxiolytic agents
DE69108743T2 (de) * 1991-01-31 1995-08-17 Pfizer Recematspaltung von trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]-pyrazin.

Also Published As

Publication number Publication date
PL330962A1 (en) 1999-06-21
CZ434998A3 (cs) 1999-11-17
IL127037A0 (en) 1999-09-22
WO1998000425A1 (en) 1998-01-08
BR9710018A (pt) 1999-08-10
TR199802743T2 (tr) 1999-03-22
ZA975806B (en) 1998-12-30
ID19779A (id) 1998-07-30
KR20000022490A (ko) 2000-04-25
AU2974497A (en) 1998-01-21
JPH11512751A (ja) 1999-11-02
EP0912569A1 (en) 1999-05-06
CN1221418A (zh) 1999-06-30
YU61098A (sh) 1999-09-27
AR008251A1 (es) 1999-12-29

Similar Documents

Publication Publication Date Title
AU645698B2 (en) 4-pyrimidinecarboxamide derivatives, their preparation and their application in therapy
CS221809B2 (en) Method of making the dextrorotary trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido/4,3-b/indole
AU632844B2 (en) Halogenoalkylphenyl-alcohols, -keytones and hydrates thereof
JP3040182B2 (ja) イミダゾピリダジン誘導体、その用途及び製造法
WO2000062782A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
GB2092144A (en) Novel indanyl derivaitves
EP0569387B1 (en) Resolution of trans-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido 1,2-a]pyrazine
CA2259496A1 (en) Preparation of (7s,trans)-2-(2-pyrimidinyl)-7-(hydroxymethyl)octahydro-2h-pyrido[1,2-a]pyrazine
US4806663A (en) Certain 3-substituted 2-alkyl benzofuran derivatives
US6670476B2 (en) Resolution of trans-7-(hydroxy-methyl)octa-hydro-2H-pyrido[1,2-a]pyrazine
US6576764B2 (en) Synthesis and crystallization of piperazine ring-containing compounds
EP0347880A2 (en) Imidazo[2,1-b]benzothiazole compounds and antiulcer compositions containing the same
US4612317A (en) Tetrahydro-β-carboline dithioic acid derivatives and treatment of liver diseases
AU781221B2 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
JP2003500333A (ja) 4−[(2’,5’−ジアミノ−6’−ハロゲンピリミジン−4’−イル)アミノ]シクロペント−2−エンイルメタノールの製造方法
PL163419B1 (pl) Sposób wytwarzania nowych pochodnych benzoksazolonu PL PL PL
WO2006013546A2 (en) Process for the preparation of pure galantamine
Harnden et al. Total synthesis of thiazolinone analogues of indolmycin
EP1337533B1 (en) Resolution of trans-7-(hydroxy-methyl)octa-hydro-2h-pyrido-1,2a)pyrazine
IL45347A (en) 7h-indolizino(5,6,7-ij)isoquinoline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
JPS5883679A (ja) 薬理学的に活性な新規1,2,3,4,4a,5,10,10a−オクタヒドロ−ベンゾ〔g〕キノリン誘導体
AU2005201117A1 (en) Novel synthesis and crystallization of piperazine ring-containing compounds
WO2006018703A2 (en) Processes for preparation of narwedine and its use in the synthesis of galantamine
JPS58189182A (ja) 五環性化合物、その製法及びそれを含む医薬組成物

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued